PEMPHIGUS
Clinical trials for PEMPHIGUS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS trials appear
Sign up with your email to follow new studies for PEMPHIGUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to tame autoimmune skin disease with fewer Flare-Ups
Disease control Recruiting nowThis study is testing a more personalized approach to managing pemphigus, a serious autoimmune disease that causes painful skin blisters. Researchers want to see if adjusting the timing and dose of a standard drug (rituximab) based on a patient's specific antibody levels works be…
Matched conditions: PEMPHIGUS
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
New hope for tough skin blister disease that defies steroids
Disease control Recruiting nowThis study is testing an investigational drug called ONO-4059 for people with pemphigus, a serious autoimmune disease that causes painful skin blisters, when standard steroid treatment has failed. About 34 participants will be randomly assigned to receive either the new drug plus…
Matched conditions: PEMPHIGUS
Phase: PHASE3 • Sponsor: Ono Pharmaceutical Co. Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Landmark study seeks to measure the hidden toll of rare skin conditions
Knowledge-focused Recruiting nowThis study aims to measure the full burden—including physical, emotional, social, and financial impacts—of living with nine rare skin diseases. Researchers will enroll 900 patients and their families across France to complete detailed surveys about their daily lives and healthcar…
Matched conditions: PEMPHIGUS
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC